Let’s get novel for rare oncology
Our late-stage rare oncology programs have the potential to be best-in-class treatments for patients with devastating diseases.
Let’s dig into BCMA combinations
in multiple myeloma
Our gamma secretase inhibitor, nirogacestat, is being evaluated as part of several B-cell maturation agent (BCMA) combination therapy regimens in collaboration with industry and academia.
Let’s take on biomarker-defined metastatic solid tumors
We are using a precision oncology approach to evaluate investigational medicines for highly-prevalent, biomarker-defined metastatic cancers in monotherapy and combination therapy studies. If successful, our programs could potentially address more than one-third of solid tumor patients.
People with devastating
diseases need more champions.
Let’s make a difference.
We understand the physical and emotional toll of living with a severe rare disease or a devastating cancer, which is why we are committed to developing new treatments for people dealing with them. Helping people live longer, healthier lives is core to our mission and central to our work.
Our values drive us
We take caring very seriously. We care about our patients deeply, intensely, and relentlessly. Every day, we care for patients by working harder to develop solutions others haven’t.
Ambition Without Ego
We exist to ignite the power of promising science to unleash new possibilities for patients. To make this audacious ambition a reality, we must not let personal pride, empty rhetoric, or ego get in the way.
Think Deeply, Act Quickly
Our team is measured, comprehensive, and thoughtful about every move we make, but we’re also driven by a sense of urgency because we know that patients are waiting. We delicately and expertly balance thinking and acting while always upholding our commitment to the highest standards of ethics and integrity.
Good Enough is Never Enough
“Good enough” is never enough for the patients and families counting on us. That’s why we constantly push ourselves to become smarter, better, and faster in pursuit of our ambition.
In It Together
We’re a team, first and foremost. Each and every SpringWorker is all in with their coworkers, partners, and patients. We do our best work when we all get together, hurling jokes and big ideas, and collectively making it happen.
One of the challenges with desmoid tumors is that they are extraordinarily aggressive locally and can grow at a relatively rapid pace. Over the course of two years, my tumor grew from the size of a small green pea to the size of a football, and it was located in my calf. My desmoid tumors completely changed my life and led to my leg being amputated.Dana, Desmoid Tumor Patient
Join the Pursuit
We give it our all every day because we believe targeted oncology is the best way to change the outlook for people with cancer. The answers are waiting. Let’s go find them together.